Evidence map›Paper›PMID 23319508›Full record

ArticleAnnals of family medicine

Primary care physicians' use of an informed decision-making process for prostate cancer screening.

Robert J Volk, Suzanne K Linder, Michael A Kallen, James M Galliher, Mindy S Spano, Patricia Dolan Mullen, Stephen J Spann

Abstract read
In one paragraph

Article in Annals of family medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Talking About Your Prostate: Perspectives from Providers and Community Members.Journal of cancer education : the official journal of the American Association for Cancer Education · 2018
    Article
  18. Article
  19. Prostate cancer screening among family physicians in Ontario: An update on attitudes and current practice.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Robert J VolkDepartment of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA. bvolk@mdanderson.org
Suzanne K Linder
Michael A Kallen
James M Galliher
Mindy S Spano
Patricia Dolan Mullen
Stephen J Spann

Funding

Health Promotion and Disease Prevention Research CentersU48DP000057 · DP · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI TORTOLERO, SUSAN · 2004 to 2009
$17.0M
BEHAVIORAL SCIENCE EDUCATION--CANCER PREVENTION/CONTROLR25CA057712 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MULLEN, PATRICIA DOLAN · 1992 to 2017
$8.6M
NCCDPHP CDC HHS U48 DP000057NCI NIH HHS R25-CA-57712
6 · The paper itself

Abstract

purposeLeading professional organizations acknowledge the importance of an informed decision-making process for prostate cancer screening. We describe primary care physicians' reports of their prescreening discussions about the potential harms and benefits of prostate cancer screening.

methodsMembers of the American Academy of Family Physicians National Research Network responded to a survey that included (1) an indicator of practice styles related to discussing harms and benefits of prostate-specific antigen testing and providing a screening recommendation or letting patients decide, and (2) indicators reflecting physicians' beliefs about prostate cancer screening. The survey was conducted between July 2007 and January 2008.

resultsOf 426 physicians 246 (57.7%) completed the survey questionnaire. Compared with physicians who ordered screening without discussion (24.3%), physicians who discussed harms and benefits with patients and then let them decide (47.7%) were more likely to endorse beliefs that scientific evidence does not support screening, that patients should be told about the lack of evidence, and that patients have a right to know the limitations of screening; they were also less likely to endorse the belief that there was no need to educate patients because they wanted to be screened. Concerns about medicolegal risk associated with not screening were more common among physicians who discussed the harms and benefits and recommended screening than among physicians who discussed screening and let their patients decide.

conclusionsMuch of the variability in physicians' use of an informed decision-making process can be attributed to beliefs about screening. Concerns about medicolegal risk remain an important barrier for shared decision making.

Indexed as

Attitude of Health PersonnelEarly Detection of CancerFamily PracticePrimary Health CareBiomarkersDirective CounselingFemaleHealth Care SurveysHumansInformed ConsentLogistic ModelsMaleMultivariate AnalysisPatient Acceptance of Health CarePatient Education as TopicPatient ParticipationBiomarkersProstate-Specific Antigen

Identifiers

PMID23319508
PMCPMC3596021

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.